Asthma rx, omalizumab, tied to late-onset anaphylaxis.(News): An article from: Family Practice News

Asthma rx, omalizumab, tied to late-onset anaphylaxis.(News): An article from: Family Practice News

This digital document is an article from Family Practice News, published by Thomson Gale on May 15, 2006. The length of the article is 490 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Asthma rx, omalizumab, tied to late-onset anaphylaxis.(News)
Author: Patrice Wendling
Public

List Price: $ 5.95

Price: $ 5.95

Information on Asthma from Gooasthma.info Choices including causes, symptoms, diagnosis, risks and treatment and with links to other useful resources.
Asthma rx, omalizumab, tied to late-onset anaphylaxis.(News): An article from: Family Practice News



More Asthma Medication Side Effects Products

---

Orignal From: Asthma rx, omalizumab, tied to late-onset anaphylaxis.(News): An article from: Family Practice News